Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 19
2017 1
2018 1
2019 119
2020 274
2021 353
2022 389
2023 341
2024 110

Text availability

Article attribute

Article type

Publication date

Search Results

1,461 results

Results by year

Filters applied: . Clear all
Page 1
Molecular targeted therapy of glioblastoma.
Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M. Le Rhun E, et al. Cancer Treat Rev. 2019 Nov;80:101896. doi: 10.1016/j.ctrv.2019.101896. Epub 2019 Sep 11. Cancer Treat Rev. 2019. PMID: 31541850 Free article. Review.
Epidemiology of Glioblastoma Multiforme-Literature Review.
Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I. Grochans S, et al. Cancers (Basel). 2022 May 13;14(10):2412. doi: 10.3390/cancers14102412. Cancers (Basel). 2022. PMID: 35626018 Free PMC article. Review.
In this review, we analyze the pathogenesis of GBM, as well as epidemiological data, by age, gender, and tumor location. The data indicate that GBM is the higher-grade primary brain tumor and is significantly more common in men. The risk of being diagnosed with glio …
In this review, we analyze the pathogenesis of GBM, as well as epidemiological data, by age, gender, and tumor location. The data indicate t …
Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.
Han L, Jiang C. Han L, et al. Acta Pharm Sin B. 2021 Aug;11(8):2306-2325. doi: 10.1016/j.apsb.2020.11.023. Epub 2020 Dec 31. Acta Pharm Sin B. 2021. PMID: 34522589 Free PMC article. Review.
In this review, we focus on nanoscale brain-targeting drug delivery strategies designed based on BBB evolutions and related applications in various brain diseases including Alzheimer's disease, Parkinson's disease, epilepsy, stroke, traumatic brain injury and brain tumo …
In this review, we focus on nanoscale brain-targeting drug delivery strategies designed based on BBB evolutions and related applications in …
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S, Shastri A, Tsolaki AG, Yasmin H, Klein L, Singh SK, Kishore U. DeCordova S, et al. Front Immunol. 2020 Jul 17;11:1402. doi: 10.3389/fimmu.2020.01402. eCollection 2020. Front Immunol. 2020. PMID: 32765498 Free PMC article. Review.
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a poor prognosis, despite surgical resection combined with radio- and chemotherapy. ...
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a poor prognosis, despite surgical resection com …
Epilepsy and brain tumors: Two sides of the same coin.
Aronica E, Ciusani E, Coppola A, Costa C, Russo E, Salmaggi A, Perversi F, Maschio M. Aronica E, et al. J Neurol Sci. 2023 Mar 15;446:120584. doi: 10.1016/j.jns.2023.120584. Epub 2023 Feb 13. J Neurol Sci. 2023. PMID: 36842341 Free article. Review.
Future trials with a prospective, randomized, and controlled design accounting for different prognostic factors will help clarify the role of these ASMs and the clinical setting in which they might be used. In conclusion, brain tumor-related epilepsies are clear exa …
Future trials with a prospective, randomized, and controlled design accounting for different prognostic factors will help clarify the role o …
Management of epilepsy in brain tumor patients.
van der Meer PB, Taphoorn MJB, Koekkoek JAF. van der Meer PB, et al. Curr Opin Oncol. 2022 Nov 1;34(6):685-690. doi: 10.1097/CCO.0000000000000876. Epub 2022 Jul 16. Curr Opin Oncol. 2022. PMID: 35838207 Free PMC article. Review.
PURPOSE OF REVIEW: A concise review of recent findings in brain tumor-related epilepsy (BTRE), with focus on the effect of antitumor treatment on seizure control and the management of antiepileptic drugs (AEDs). ...
PURPOSE OF REVIEW: A concise review of recent findings in brain tumor-related epilepsy (BTRE), with focus on the effect of ant …
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.
Lin YJ, Mashouf LA, Lim M. Lin YJ, et al. Front Immunol. 2022 Feb 21;13:817296. doi: 10.3389/fimmu.2022.817296. eCollection 2022. Front Immunol. 2022. PMID: 35265074 Free PMC article. Review.
The remarkable clinical effect seen with CAR T cell therapies against hematological malignancies have attracted interest in developing such therapies for solid tumors, including brain tumors. Glioblastoma (GBM) is the most common primary brain tumor in adults and is …
The remarkable clinical effect seen with CAR T cell therapies against hematological malignancies have attracted interest in developing such …
Brain Tumor Networks in Diffuse Glioma.
Yang Y, Schubert MC, Kuner T, Wick W, Winkler F, Venkataramani V. Yang Y, et al. Neurotherapeutics. 2022 Oct;19(6):1832-1843. doi: 10.1007/s13311-022-01320-w. Epub 2022 Nov 10. Neurotherapeutics. 2022. PMID: 36357661 Free PMC article. Review.
Increasing evidence has shown how neurodevelopmental and neuronal-like mechanisms are hijacked leading to the discovery of multicellular brain tumor networks. Here, we review how gap junction-coupled tumor-tumor-astrocyte networks, as well as synaptic and paracrine …
Increasing evidence has shown how neurodevelopmental and neuronal-like mechanisms are hijacked leading to the discovery of multicellular …
1,461 results